BOCA RATON, FL, NY — October 14, 2025 — Leads & Copy — Entero Therapeutics (NASDAQ:ENTO) has strategically repositioned itself by acquiring GRID AI, entering the race to balance energy demand with the needs of artificial intelligence.
GRID AI’s Dynamic Load Shaping and Aggregation Management Platform turns volatility into reliability, enabling operators to plan and deliver power where needed. Goldman Sachs projects a significant rise in global data center demand, straining existing grids. GRID AI synchronizes data surges, renewable energy spikes, and EV charging.
GRID AI stakeholders now hold over eighty percent of Entero equity. The convergence of supply scarcity and orchestration technology is poised to impact the market, providing a rare opportunity for public investors. GRID AI’s technology offers a conductor, and Entero provides the rare public stage.
GRID AI provides Dynamic Load Shaping™, DER aggregation, and AI-driven orchestration. Its Aggregation Management Platform uses IoT, AI/ML, and edge analytics to manage flexible demand across millions of devices for utilities and energy users. Entero Therapeutics is a biopharmaceutical company focused on GI diseases. Following the GRID AI acquisition, ENTO will operate GRID AI as a subsidiary.
Contact email: info@hawkpointmedia.com
Source: Entero Therapeutics
